Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FFNP-PET/CT to Predict Endocrine Therapy Response in Breast Cancer
NCT02455453Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Apr 2015
- Primary completion
- Jan 2019
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Washington University School of Medicine. Primary endpoints: Change in Primary Tumor FFNP Uptake Before and After Estradiol Challenge up to 4 weeks and Change in Secondary Tumor FFNP Uptake Before and After Estradiol Challenge up to 4 weeks. Started Apr 2015; status: completed.
Beyond the preview
Go deeper on NCT02455453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02455453.